GE HealthCare Technologies Inc (GE HealthCare) is a medical technology, pharmaceutical diagnostics, and digital solutions company. It designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing, and cellular technologies; imaging agents used during medical scanning procedures; and healthcare IT solutions. GE HealthCare also provides services such as performance improvement and performance solutions services, computerized data management, and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE HealthCare is headquartered in Chicago, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GE HealthCare Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Tandem Diabetes Care Inc Company Overview
- Tandem Diabetes Care Inc Company Snapshot
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc - Pipeline Analysis Overview
- Tandem Diabetes Care Inc - Key Facts
- Tandem Diabetes Care Inc - Major Products and Services
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Pipeline Products Overview
- Control-IQ
- Product Status
- CSII Catheter
- CSII Catheter Product Overview
- Integrated Insulin Delivery System with Dual Glucose-Ketone Sensor
- Integrated Insulin Delivery System with Dual Glucose-Ketone Sensor Product Overview
- Next Generation Closed Loop
- Next Generation Closed Loop Product Overview
- Next Generation Gswim
- Next Generation Gswim Product Overview
- SteadiSet Infusion Set
- SteadiSet Infusion Set Product Overview
- SteadiSet Infusion Set Clinical Trial
- t:connect Mobile - Biometric Authentication
- t:connect Mobile - Biometric Authentication Product Overview
- t:connect Mobile - Decision Support
- t:connect Mobile - Decision Support Product Overview
- t:connect Mobile - Health App Integration
- t:connect Mobile - Health App Integration Product Overview
- t:slim X3 Insulin Pump
- t:slim X3 Insulin Pump Product Overview
- Tandem Mobi: Tubeless
- Tandem Mobi: Tubeless Product Overview
- Tandem Patch
- Tandem Patch Product Overview
- Tandem Diabetes Care Inc - Key Competitors
- Tandem Diabetes Care Inc - Key Employees
- Tandem Diabetes Care Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tandem Diabetes Care Inc, Recent Developments
- Jul 01, 2026: Tandem Diabetes Care Launches T:Slim X2 Insulin Pump Compatibility With Abbott Freestyle Libre 3 Plus Sensor in Five International Markets
- Jun 08, 2026: Tandem secures CE mark for AID systems in T2D and T1D with pregnancy
- Jun 05, 2026: andem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
- May 01, 2026: Tandem Diabetes Care Received Additional 510(K) Clearance For Control-IQ
- Apr 28, 2026: Tandem secures FDA approval for Control-IQ+ use in pregnancy
- Mar 04, 2026: Tandem Mobi Now Compatible with Android Smartphones
- Feb 12, 2026: Tandem Diabetes Care Announces Upcoming Conference Presentations
- Jan 08, 2026: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
- Dec 18, 2025: Tandem t:slim Mobile App Now Available in Canada
- Nov 19, 2025: Tandem Diabetes Care Receives an Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Indication
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc, Key Facts
- Tandem Diabetes Care Inc, Major Products and Services
- Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Ongoing Clinical Trials Summary
- Product Status
- Control-IQ - Product Description
- CSII Catheter - Product Status
- CSII Catheter - Product Description
- Integrated Insulin Delivery System with Dual Glucose-Ketone Sensor - Product Status
- Integrated Insulin Delivery System with Dual Glucose-Ketone Sensor - Product Description
- Next Generation Closed Loop - Product Status
- Next Generation Closed Loop - Product Description
- Next Generation Gswim - Product Status
- Next Generation Gswim - Product Description
- SteadiSet Infusion Set - Product Status
- SteadiSet Infusion Set - Product Description
- SteadiSet Infusion Set - Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
- t:connect Mobile - Biometric Authentication - Product Status
- t:connect Mobile - Biometric Authentication - Product Description
- t:connect Mobile - Decision Support - Product Status
- t:connect Mobile - Decision Support - Product Description
- t:connect Mobile - Health App Integration - Product Status
- t:connect Mobile - Health App Integration - Product Description
- t:slim X3 Insulin Pump - Product Status
- t:slim X3 Insulin Pump - Product Description
- Tandem Mobi: Tubeless - Product Status
- Tandem Mobi: Tubeless - Product Description
- Tandem Patch - Product Status
- Tandem Patch - Product Description
- Tandem Diabetes Care Inc, Key Employees
- Tandem Diabetes Care Inc, Subsidiaries
- Glossary
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
